At Asherman Care, we are committed to the prevention and treatment of Asherman syndrome.
Our Philosophy
Our approach to the treatment of Asherman syndrome is based on the understanding that intrauterine scarring — the cause of Asherman syndrome — results from inadequate healing within the uterine cavity.
Our focus is not only on the surgical removal of scar tissue, but also on promoting healthy healing within the uterus to help prevent the recurrence of Asherman syndrome.
To support this approach, Asherman Care is committed to:
Providing timely access to care
We endeavour to offer consultation appointments within three weeks of receiving a valid referral from your GP or specialist.
Delivering comprehensive care in one location
Consultations, ultrasounds and post-procedure intrauterine instillations are performed in-house at WHRIA. Appointments are coordinated to make planning as efficient and convenient as possible for patients. Surgical procedures are undertaken in an operating theatre.
Advancing research and clinical knowledge
We remain committed to ongoing research and clinical advancement to improve treatment outcomes for Asherman syndrome and to better understand how the condition may be prevented.
We believe that supporting optimal healing of the uterine cavity should be considered whenever trauma to the uterus has occurred.
Our treatment protocol for Asherman syndrome has been developed by Professor Thierry Vancaillie over more than 20 years of clinical experience and research.
Over the course of approximately one week, patients undergo detailed ultrasound diagnosis and surgical planning, the surgical removal of scar tissue, careful measures to minimise trauma and infection, and therapies designed to promote healthy healing within the uterus.
Background artwork by Professor Thierry Vancaillie.
Our Services
We provide specialised care for women requiring assessment, treatment, and follow-up for miscarriage and Asherman syndrome.
Our services include miscarriage advice, miscarriage management, assessment for suspected Asherman syndrome, and comprehensive treatment and follow-up care for intrauterine adhesions.
Our approach combines advanced diagnostic imaging, expert surgical treatment, and carefully coordinated follow-up care to support healing of the uterine cavity and improve long-term reproductive outcomes.
Each stage of care is designed to provide accurate diagnosis, effective treatment, and ongoing support throughout recovery.
Miscarriage Advice
A miscarriage occurs when a pregnancy ends before the 20th week of gestation. Miscarriage is unfortunately common, affecting approximately 1 in 4 pregnancies. While common, it can be a very difficult experience for women and their families.
If you have been diagnosed with a miscarriage, and there is no suspicion of an ectopic or molar pregnancy, you should discuss the available management options with your care provider (such as your hospital early pregnancy service or gynaecologist).
Management options may include:
- Conservative management – allowing the miscarriage to occur naturally (“wait and see”)
- Medical management
- Surgical management
Miscarriage Management
Doctors at WHRIA are available to discuss and manage miscarriage care.
When surgical management is recommended, the preferred technique is suction curettage performed under real-time sonographic guidance. The aim of the procedure is the complete removal of miscarriage tissue while minimising injury to the uterine cavity.
Antibiotics are commenced prior to the procedure to reduce the risk of infection, which is a known risk factor for the development of Asherman syndrome.
To further support healing of the uterine cavity, there is also the option of instilling oestradiol-containing hyaluronic acid into the uterus at the completion of the procedure.
Asherman Advice
Asherman syndrome is a condition caused by scar tissue within the uterus (intrauterine adhesions).
Intrauterine adhesions may develop after pregnancy, following surgical procedures involving the uterus, as a result of infection, or in some cases for reasons that remain unknown.
Some women with intrauterine adhesions experience reduced or absent menstrual bleeding. Others may have no noticeable symptoms but may face an increased risk of infertility or miscarriage.
If Asherman syndrome is suspected, it can be investigated using a sonohysterogram, a specialised internal pelvic ultrasound that involves the infusion of sterile saline into the uterine cavity.
Asherman Treatment and Follow-Up
Our treatment of Asherman syndrome follows a carefully developed clinical protocol.
Timing of the procedure
Surgical removal of intrauterine adhesions is ideally performed during the early proliferative phase of the menstrual cycle, shortly after menstruation.
Antibiotic prophylaxis
Operating on a uterus containing scar tissue, retained pregnancy tissue, or trapped old blood may increase the risk of infection. Because infection can contribute to the development or recurrence of Asherman syndrome, we prescribe a one-week course of antibiotics, beginning two days before the procedure.
Principles of the procedure
The procedure is performed in an operating theatre under general anaesthetic. Image intensifier technology and trans-abdominal ultrasound are used to guide the surgery.
Hysteroscopy with specialised mechanical micro-instruments allows precise removal of scar tissue, micro-calcifications, and any remaining products of conception. In some cases, micro-calcifications may extend into the myometrium, making removal more technically challenging.
The goal is to remove as much scar tissue as possible while avoiding unnecessary risk. Occasionally, more than one procedure may be required to achieve optimal results.
Stimulating healthy healing
Following surgery, we support the regrowth of the endometrium to cover the treated surfaces of the uterus. Patients are prescribed oestradiol therapy, taken both orally and transdermally.
At the time of the procedure, healing may also be supported through the intrauterine instillation of therapeutic agents such as Platelet-Rich Plasma (PRP), hyaluronic acid, and oestradiol.
This area of treatment continues to evolve, and ongoing research is focused on identifying therapies that may further improve healing and treatment success.
Immediate follow-up care
During the week following surgery, patients return to WHRIA for continued stimulation of the endometrium through repeat instillations of hyaluronic acid and oestradiol.
Our Team
At WHRIA, patients have access to advanced diagnostic imaging, expert hysteroscopic treatment, and coordinated follow-up care delivered by a multidisciplinary team with experience in the diagnosis and management of Asherman syndrome.
We are committed to ongoing research into both the prevention and treatment of Asherman syndrome.
In 2020, our service published the world’s largest single-operator audit of the treatment of Asherman syndrome.
Current research focuses on pregnancy outcomes following treatment of Asherman syndrome and exploring new methods to further improve treatment success.
Contact Us
Asherman Australia proudly operates at
PHONE
1300 722 206
info@ashermancare.com.au
FAX
(02) 8021 1244
OPENING HOURS
Monday - Friday, 8:00am – 5:00pm
Got Questions? Talk to us.
Please fill out the form below and our team will get back to you as soon as we can.